COVID-19 Sample Collection Kits Market Research Report - Forecast till 2027

COVID-19 Sample Collection Kits Market: By Product Type (Swabs, Viral Transport Media, Blood Collection Kits, Others), Application (Diagnostics, Research), End-User (Hospitals & Clinics, Diagnostic Centers, Others) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast to 2027

ID: MRFR/HC/8291-HCR | February 2021 | Region: Global | 120 pages

COVID-19 Sample Collection Kits Market Forecast


COVID-19 Sample Collection Kits Market is expected to hold a value of USD 4168.35 Million by 2027 and COVID-19 Sample Collection Kits Market is expected to register a growth of 5.20% from 2020 to 2027.


Market Synopsis


The sample collection kit means the vitals and reagents provided for use in collecting samples and shipping them to the laboratory at which the testing services will be performed on such a sample. The high demand for sample collection kits, due to the outbreak of COVID-19 globally, and approval of new & advanced detection tests by authorities are the key factors that are expected to drive the COVID-19 sample collection kits market growth. The Food and Drug Administration (FDA), in May 2020, has issued an emergency use authorization (EUA) to Everlywell, Inc. for the COVID-19 Test Home Collection Kit. The product is a standalone, at home, nasal swab sample collection kit that can be sent to specified labs for subsequent COVID-19 diagnostic testing. Thus, there is an increase in demand for sample collection kits. Moreover, the detection of antibodies, rise in government funding, and large volume of products & usage rate of swabs are also expected to boost the COVID-19 sample collection kits market growth.


Market Influencer


The outbreak of COVID-19, leading to increased demand for the COVID-19 sample collection kit market.


Market Drivers



  • High demand for sample collection kits, due to the outbreak of COVID-19 globally.



  • Approval of detection tests by regulatory authorities. These tests are based on four different techniques such as reverse transcription-polymerase chain reaction (RT-PCR), loop-mediated isothermal amplification (LAMP), Lateral flow, and Enzyme-linked immunosorbent assay (ELISA).



  • Large volume and usage rate of swabs. California- based medical device manufacturer, IPB Inc. has been working for the production of new swabs, nearly 2, 00,000 per day.



  • Rise in the detection of antibodies



  • Increase in government funding.



  • Rise in at-home kits for reducing the risk of transmitting the virus.


Market Restraints



  • Shortage of test-related supplies such as reverse transcription-polymerase chain reaction instruments, swabs, and virus control samples to control.



  • Lack of laboratory-based reagents


COVID-19 sample collection kits MarketSegmentation


By Product Type



  • Swabs: Swabs are a small piece of soft material used for cleaning a cut or for taking a small amount of substance from a body, or the substance itself that can be tested. According to the Centers for Disease Control and Prevention (CDC), May 2020 report, sterile swabs for upper respiratory specimen collection can be packaged in two ways i.e., individually wrapped and bulk packaged.

    • Nasopharyngeal (NP) Swabs: A nasopharyngeal swab is a method for collecting a clinical test sample of nasal secretions from the back of the nose and throat. This is the fastest-growing segment.

    • Oropharyngeal (OP) Swabs: An oropharyngeal swab is a method to identify germs or viruses that may cause infection in the throat.





  • Viral Transport Media: Viral transport media is the largest growing segment. These are essential kits that contain transport media in a tube as well as the swab.



  • Blood Collection Kits: The blood collection kit is designed for use by medical personnel to aid in the collection of a whole blood sample.



  • Others: Other product type includes specimen collection. This is the process of obtaining tissue or fluids for laboratory analysis or near-patient testing.


By Application



  • Diagnostic: For diagnosis, the COVID-19 sample collection kit permits samples collected from the patient’s nose using a designated self-collection kit that contains nasal swabs and saline. This segment is the fastest-growing segment.



  • Research: For research, the COVID-19 sample collection kit is used to collect samples from patients, and research is conducted for introducing vaccines or medications for preventing diseases. This segment is the largest growing segment.


By End-User



  • Hospitals & Clinics: Hospitals & clinics segment is the largest segment with an increasing need for testing COVID-19 among communities. Many airtight cabins are arranged for collecting swab samples to prevent the infection from spreading. This is the largest growing segment.



  • Diagnostics Centers: Diagnostic center is the fastest-growing segment. These centers help in the expansion of molecular diagnostic screening with increased usage of swabs and viral transport media for applications during diagnosis.



  • Others: Other end-users include a home test, which enables an individual to collect a sample at home and prevent the transmission of diseases.


By Region



  • Americas: According to the US Food and Drug Administration (FDA), April 2020, Laboratory Corporation of America (LabCorp) is the first diagnostic test developer for at-home specimen collection kit for COVID-19. This is expected for the high demand for sample collection kits across the region during the forecast period.



  • Europe: As per MRFR, 2, 95,889 cases of COVID-19 were confirmed in the United Kingdom. Furthermore, according to the World Health Organization (WHO), January 2020 report, the World Health Organization (WHO), and the European Centre for Disease Prevention and Control (ECDC), moved quickly to identify the laboratory needs and capacities in the European region. Thus, sample collection kits are required for laboratory tests and detection due to a rise in the number of confirmed cases of COVID-19, which is expected to drive the COVID-19 sample collection kits market growth.



  • Asia-Pacific: Due to the outbreak of COVID-19 cases, the Asian Development Bank (ADB), in March 2020, announced a USD 6.5 billion aid package for the Asia-Pacific region. Thus, an increase in government funding is expected to drive the COVID-19 sample collection kits market growth.



  • Middle East & Africa: The Middle East & Africa region is more under proper infrastructure development and advancement of technology. This leads to low development in the healthcare industry which reduces the production of sample collection kits in the market. To overcome, rise in development and technology is expected to drive the COVID-19 sample collection kits market growth.


COVID-19 Sample Collection Kits Market Key Players



  • Thermo Fisher Scientific, Inc.

  • Hardy Diagnostics

  • BNTX Inc.

  • Formlabs

  • Medline Industries, Inc.

  • HiMedia Laboratories

  • VIRCELL S.L.

  • Puritan Medical Products

  • COPAN Diagnostics

  • Becton, Dickinson, and Company

  • Laboratory Corporation of America Holdings

  • Lucence Diagnostics Pte Ltd.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 4168.35 Million
  CAGR   5.20% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type and Application
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Thermo Fisher Scientific, Inc. (US), Hardy Diagnostics (US), BNTX Inc. (Germany), Formlabs (US), Medline Industries, Inc. (US), HiMedia Laboratories (India), VIRCELL S.L. (Spain), Puritan Medical Products (US), COPAN Diagnostics (California), Becton, Dickinson, and Company (US), Laboratory Corporation of America Holdings (US), Lucence Diagnostics Pte Ltd. (California).
  Key Market Opportunities   The Outbreak of COVID-19, Leading to Increased Demand for the COVID-19 Sample Collection Kit.
  Key Market Drivers

  • Approval of Detection Tests by Regulatory Authorities.
  • Large Volume and Usage Rate of Swabs.
  • Rise in the Detection of Antibodies.
  • Increase in Government Funding.
  • Rise in at-home kits for reducing the risk of transmitting the virus.\r\n


  • Frequently Asked Questions (FAQ) :


    The sample collection kit means the vitals and reagents provided for use in collecting samples and shipping them to the laboratory at which the testing services will be performed on such a sample.

    Swabs are a small piece of soft material used for cleaning a cut or for taking a small amount of substance from a body, or the substance itself that can be tested. According to the Centers for Disease Control and Prevention (CDC), May 2020 report, sterile swabs for upper respiratory specimen collection can be packaged in two ways i.e., individually wrapped and bulk packaged.

    COVID-19 Sample Collection Kits Market is expected to hold a value of USD 4168.35 Million by 2027 and is expected to register a growth of 5.20% from 2020 to 2027.

    COVID-19 Sample Collection Kits Market is expected to hold a value of USD 4168.35 Million by 2027

    COVID-19 Sample Collection Kits Market is expected to register a growth of 5.20% By 2027

    High demand for sample collection kits, due to the outbreak of COVID-19 globally. Approval of detection tests by regulatory authorities. Large volume and usage rate of swabs. Rise in the detection of antibodies Increase in government funding. Rise in at-home kits for reducing the risk of transmitting the virus.

    On the basis of product type, the market has been segmented into swabs, viral transport media, blood collection kits, and others. The swabs segment is anticipated to be the fastest-growing segment

    Some of the key players in the global COVID-19 sample collection kits market are Thermo Fisher Scientific, Inc. (US), Hardy Diagnostics (US), BNTX Inc. (Germany), Formlabs (US), Medline Industries, Inc. (US), HiMedia Laboratories (India), VIRCELL S.L. (Spain), Puritan Medical Products (US), COPAN Diagnostics (California), Becton, Dickinson, and Company (US), Laboratory Corporation of America Holdings (US), Lucence Diagnostics Pte Ltd. (California)



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.